• Medicine 1

    When patients are involved, medical research results become meaningful solutions

  • Medicine 2

    We provide patient input to the latest research for chronic diseases

  • Medicine 3

    Improving patient knowledge and involvement in clinical trials

Medical devices can increase life expectancy and quality of life. They are also fundamental for chronic disease patients as they help them manage their symptoms, contributing to patient-centred and disease self-management. Medical devices cover a huge spectrum of products, from home-use items such as sticking plasters, contact lenses and pregnancy tests to dental filling materials, x-ray machines, pacemakers, breast implants, hip replacements and HIV blood tests.

Medical devices legislation

Rules relating to the safety and performance of medical devices were harmonised in the EU in the 1990s, but the existing regulatory framework does not correspond anymore with the current situation in terms of technological and scientific progress. To overcome this situation, the European Commission proposed changes to the legislations on medical devices and in-vitro diagnostic medical devices. If they are adopted by the European Parliament and the Council, they will replace the existing European legal framework that regulates among others inhalers, nebulisers and adrenaline injectors, which are vital for patients with asthma, allergy and COPD.

Inhalers, nebulisers and adrenaline injectors are widely used medical devices for asthma and COPD patients. They are small, handheld devices that deliver a puff of medicine into the airways. Inhalers and nebulisers have the same purpose: to get the drugs into the lungs where you need them. Both deliver the same types of medicine and both are equally effective when used properly. In case of anaphylaxis, the lives of allergic patients having a record of severe allergic reactions can be saved thanks to a medical device that injects epinephrine into their bodies.

Given the importance of medical devices for asthma, allergy and COPD patients, we at EFA advocate for:

  • A stricter regulation with increased patient involvement of medical devices that ensures patient safety above market conditions;
  • m-Health solutions to be considered in certain cases as medical devices;
  • Systematic quality check and control of medical devices components with greater transparency and information provided to the public.

EFA documents and activities in medical devices

Tags: Category: Briefing
Country: EU
Disease area: Asthma,Allergy,COPD
Theme: - Medical Devices

What's new - Medical devices

EFA's Roberta Savli participated on the 25th of January in the Stakeholder Forum meeting of the BBMRI-ERIC. The meeting served to identify the priorities of action and to organize and agree on the wor ...


On the 31st of January, the European Commission published a new proposal for Health Technology Assessment (HTA) cooperation in the European Union (EU)  beyond 2020. EFA welcomes this announcement ...


Latest research - Medical devices

In November 2016, we met in Manchester with our partners of the Horizon 2020 project myAirCoach to track the status quo in all work-packages, the main results achieved in 2016 and to plan the third an ...


EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...


Key Facts

500,000 medical technologies
are available to healthcare professionals

medical technology companies in Europe

of sales is spent on research and development